India's pharmaceutical industry is poised for significant growth, with its share in the global market expected to rise to 5 ...

The Indian pharma market, currently valued at around USD 55 billion, is projected to expand 2.2 to 2.4 times over the next ...

However, P V Appaji, former director general of Pharmexcil finds that the interest of Indian companies to get approvals for ...

Countries that have free trade agreements with the US, such as Singapore and South Korea, are safer with respect to Trump's ...

India's pharmaceutical exports are projected to reach USD 65 billion by 2030, with a target of USD 350 billion by 2047, ...

India's pharmaceutical exports are projected to reach US$ 350 billion by 2047, driven by specialty generics, biosimilars, and APIs.

Mugunthan Siva, Managing Director of India Avenue Investment Management, believes Indian IT firms are well-positioned to lead ...

Indian pharmaceutical companies lag behind global peers in ESG practices, facing regulatory, awareness, and resource ...

Shares of AstraZeneca Pharma India Ltd closed at ₹7,450 on the BSE, down 1.29% ahead of the earnings announcement.

One might think that a pharmaceutical ingredients company that boasts clients in 80 countries, certification from several ...

While India is the largest supplier of generic drugs globally, accounting for one in five generic drugs sold worldwide, the ...

India’s CDMO market has seen a record growth trajectory due to cost advantages, technological advancements, and strong ...